American Society of Hematology, 2025 (ASH) 7 - 9 December 2025

Immunogenicity Assessment of Concizumab in Patients with Hemophilia A and B: Assays Developed to Measure Anti-Drug Antibodies and Integrated Results from Clinical Trials

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Haemophilia
Congress poster
Concizumab